Profiles: Page 6

The latest opinion pieces by industry thought leaders

  • A portrait of Dawn Berry framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dawn Berry
    Image attribution tooltip

    Entrepreneurs: Dawn Barry

    The co-founder and president of LunaPBC is seeking to eliminate the middlemen in drug development by connecting patients — and their real-world data — directly with researchers.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of David Katz framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by David Katz
    Image attribution tooltip

    Entrepreneurs: David Katz

    As the founder and chief scientific officer of Sparrow Pharmaceuticals, David Katz is breathing new life into drugs that have previously been shelved.

    Michael Gibney • Sept. 6, 2022
  • A portrait of Dr. Cristian Massacesi framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Cristian Massacesi
    Image attribution tooltip

    Innovators: Dr. Cristian Massacesi

    With the goal of redefining how medicines are made, the CMO and oncology CDO is transforming AstraZeneca’s oncology development.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Chris Round framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Chris Round
    Image attribution tooltip

    Legacy Leaders: Chris Round

    The president of EMD Serono, the U.S. and Canadian healthcare business unit of Merck KGaA, Darmstadt, Germany, has the company firing on all cylinders for near- and long-term growth.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Charlene Stern framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Charlene Stern
    Image attribution tooltip

    Disrupters: Charlene Stern

    How the chief lawyer of Editas Medicine is using a multi-lens approach to bolster the development of game-changing genomic medicines.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Carol Lynch framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Carol Lynch
    Image attribution tooltip

    Legacy Leaders: Carol Lynch

    The chief business officer for Sandoz combines a shrewd business sense with a generous approach to leadership.

    Alexandra Pecci • Sept. 6, 2022
  • A portrait of Carl Turner framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Carl Turner
    Image attribution tooltip

    Disrupters: Carl Turner

    How Klick’s first-ever chief brand strategy officer is relying on collaboration to advance innovative strategies for clients and opportunities for people of color.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Bobak Azamian framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Bobak Azamian
    Image attribution tooltip

    Entrepreneurs: Dr. Bobak Azamian

    The CEO is bringing his vision for innovative eye therapies to Tarsus Pharmaceuticals.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Beth Crouse framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Beth Crouse
    Image attribution tooltip

    Entrepreneurs: Beth Crouse

    The 2nd Spark CEO is on a mission to create ‘brand fans’ and bring meaningful marketing experiences to healthcare.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Ben Yerxa framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Ben Yerxa
    Image attribution tooltip

    Entrepreneurs: Ben Yerxa

    The CEO in retinal diseases sees opportunities for drug development success by merging the work of a gene therapy startup with venture philanthropy.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Dr. Barbara Wirostko framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Barbara Wirostko
    Image attribution tooltip

    Entrepreneurs: Dr. Barbara Wirostko

    Qlaris Bio’s CMO and co-founder has her sights on bringing life-changing treatments to patients with debilitating eye diseases.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Barbara Klencke framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Barbara Klencke
    Image attribution tooltip

    Innovators: Dr. Barbara Klencke

    The chief medical officer at Sierra Oncology, a GSK company, is working to make high-impact changes for rare cancer patients.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Baba Shetty framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Baba Shetty
    Image attribution tooltip

    Tech Wizards: Baba Shetty

    The pragmatic president of technology and data solutions at Syneos Health helps healthcare companies do what they imagine.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Armon Sharei framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Armon Sharei
    Image attribution tooltip

    Entrepreneurs: Armon Sharei

    The CEO of SQZ Biotech is leveraging a technology platform that is simple in its design yet targeted at making cell therapy to break down barriers to the treatments.

    Michael Gibney • Sept. 6, 2022
  • A portrait of Ann Barnes framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Ann Barnes
    Image attribution tooltip

    DE&I Champions: Ann Barnes

    The CEO of Intelligent Medical Objects is growing her company’s diversity initiatives — and its bottom line.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Andrew Miller framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Andrew Miller
    Image attribution tooltip

    Entrepreneurs: Andrew Miller

    The founder and COO of Karuna Therapeutics is leveraging a combination of persistence and adaptability to scale up the biopharmaceutical company.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Amy C. Peterson framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Amy C. Peterson
    Image attribution tooltip

    Innovators: Dr. Amy Peterson

    The president and chief operating officer of CytomX is fighting to change the course of cancer as a leader in cutting-edge treatments.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Amanda Ryan framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Amanda Ryan
    Image attribution tooltip

    DE&I Champions: Amanda Ryan

    G3 Life Sciences’ president is lighting a fire to increase access to healthcare and diversity in trials.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Adrelia Allen framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Adrelia Allen
    Image attribution tooltip

    DE&I Champions: Adrelia Allen

    Merck & Co.’s senior director of clinical trial patient diversity is transforming the pharma giant’s approach to inclusion and equality.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Abigail Jenkins framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Abigail Jenkins
    Image attribution tooltip

    Disrupters: Abigail Jenkins

    With the belief that empathy is critical to leadership, the former chief commercial and business officer of Lyndra Therapeutics has a strong track record of building teams and accelerating progress.

    Meagan Parrish • Sept. 6, 2022
  • inside cell
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Leading the industry’s next potential game-changer in drug discovery

    Rachel Meyers, chief scientific officer at Faze Medicines, is helping guide the company towards the development of biomolecular condensates — an emerging field that could transform drug discovery.

    Alexandra Pecci • Aug. 29, 2022
  • Son holding father's hand at the hospital
    Image attribution tooltip
    FG Trade via Getty Images
    Image attribution tooltip

    The power of the underdog: A rare disease nonprofit working to help patients win against the odds

    Elizabeth Izard Apelles is finding innovative ways to champion rare disease patients through an emerging platform from Honeycomb Health.

    Alexandra Pecci • July 13, 2022
  • SaNOtize CEO Gilly Regev
    Image attribution tooltip
    Permission granted by SaNOtize/Gilly Regev
    Image attribution tooltip

    From vineyards to antivirals, Gilly Regev brings creative thinking to science

    The CEO of SaNOtize is tapping into outside-the-box innovation to develop a nitric oxide-delivery platform to treat and prevent COVID-19.

    Alexandra Pecci • June 27, 2022
  • Image attribution tooltip
    Michael Ciaglo / Stringer via Getty Images
    Image attribution tooltip

    Buoyed by COVID-19 shot, J&J's vaccines head sees a new golden age approaching

    Janssen’s goal to have ‘a vaccine for the world’ is part of what drew Penny Heaton to the company and its work.

    Alexandra Pecci • June 14, 2022
  • drug development
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    After losing her daughter to a rare disease, Sharon King is looking to rewrite the playbook of drug development

    The communications pro is lending her community-building, storytelling expertise to the Bespoke Gene Therapy Consortium.

    Alexandra Pecci • June 7, 2022